Document is current
Any future updates will be listed below
-
Authors
Mariappan, Aruljothi https://orcid.org/0000-0001-5286-9806
Soni, Komal
Schorpp, Kenji
Zhao, Fan
Minakar, Amin
Zheng, Xiangdong
Mandad, Sunit
Macheleidt, Iris
Ramani, Anand
Kubelka, Tomáš
Dawidowski, Maciej
Golfmann, Kristina
Wason, Arpit
Yang, Chunhua
Simons, Judith
Schmalz, Hans‐Günther
Hyman, Anthony A
Aneja, Ritu
Ullrich, Roland
Urlaub, Henning
Odenthal, Margarete https://orcid.org/0000-0002-2424-0960
Büttner, Reinhardt
Li, Haitao https://orcid.org/0000-0001-6741-293X
Sattler, Michael https://orcid.org/0000-0002-1594-0527
Hadian, Kamyar
Gopalakrishnan, Jay https://orcid.org/0000-0002-0639-8705
-
Funding
Funding for this research was provided by:
Human Frontier Science Program (RGY0064/2015)
Deutsche Forschungsgemeinschaft (GO 2301/2‐2)
- License Information
-
More Information
Article History
Received: 22 May 2018
Revised: 11 October 2018
Accepted: 18 October 2018
First Online: 10 December 2018
Conflict of interest
: The authors declare they have no conflict of interest. The University of Cologne has filed a European patent application related to the structures, syntheses, and uses of CCB02 and chemically related CCB02 inhibitors. Requests for CCB02 should be directed to JG (jay.gopalakrishnan@hhu.de).
